Screener
Alto Neuroscience ANRO Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Alto Neuroscience’s reported figures.
The source filing: Alto Neuroscience’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001999480-26-000012
FAQ
- What is Alto Neuroscience's free cash flow?
- Alto Neuroscience (ANRO) reported free cash flow of -$27.65M in Q1 2026.
- How has Alto Neuroscience's free cash flow changed year-over-year?
- Alto Neuroscience's free cash flow decreased by 66.7% year-over-year, from -$16.58M to -$27.65M.
- What is the long-term trend for Alto Neuroscience's free cash flow?
- Over 2 years (2023 to 2025), Alto Neuroscience's free cash flow has grown at a 23.6% compound annual growth rate (CAGR), from -$33.92M to -$51.79M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Alto Neuroscience's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude